Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Wiltrom Co., Ltd. (6767:TWSE), powered by AI.
Wiltrom Co., Ltd. is currently trading at $24.80. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Wiltrom Co., Ltd. on Alpha Lenz.
View Wiltrom Co., Ltd.'s valuation metrics on Alpha Lenz.
“Wiltrom Co., Ltd.'s ROE is -3.3%. Explore profitability and growth together.”
Ask for details →Wiltrom Co., Ltd. is a medical device manufacturer specializing in the development and production of advanced implantable medical equipment, particularly for spinal applications. Established in 2009 as a spin-off from the Industrial Technology Research Institute and headquartered in Zhubei, Taiwan, the company focuses on Class II and Class III medical devices. Its primary product portfolio includes spinal fixation systems, interbody fusion cages, bone graft substitutes, vertebroplasty bone cement, and comprehensive vertebral body augmentation systems. These products are integral to spinal fusion and compression fracture surgeries, with a core emphasis on innovation and high-quality solutions for improving patient care. Wiltrom Co., Ltd. serves markets across Taiwan, Asia, America, and Europe, playing a significant role in the healthcare equipment and supplies sector. Its expertise contributes to advancing surgical outcomes in orthopedics and neurosurgery, reinforcing its presence within the specialized field of spinal medical technologies.
“Wiltrom Co., Ltd.'s ROE is -3.3%. Explore profitability and growth together.”
Ask for details →Wiltrom Co., Ltd. (ticker: 6767) is a company listed on TWSE in the Healthcare sector (Medical Devices). It has approximately 51 employees.
The current price is 24.8 with a P/E ratio of -x and P/B of -x.
ROE is -3.28% and operating margin is -9.11%. Annual revenue is $312M.